Free tool
FAERS Monitor: Qdolo
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 214044 or its brand name (Qdolo, Tramadol Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
38,125
Serious
34,463
90% of reports
Hospitalization
11,960
Death reported
7,644
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dependence7,835
- overdose3,935
- vomiting3,558
- pain3,205
- nausea3,006
- drug ineffective2,824
- dyspnoea2,557
- off label use2,551
- headache2,496
- fatigue2,488
- drug hypersensitivity2,376
- drug dependence2,205
- pneumonia2,175
- dizziness2,143
- malaise2,106
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 115 |
| 2005 | 129 |
| 2006 | 94 |
| 2007 | 50 |
| 2008 | 124 |
| 2009 | 230 |
| 2010 | 564 |
| 2011 | 492 |
| 2012 | 936 |
| 2013 | 669 |
| 2014 | 631 |
| 2015 | 990 |
| 2016 | 1,030 |
| 2017 | 1,555 |
| 2018 | 1,820 |
| 2019 | 2,299 |
| 2020 | 2,128 |
| 2021 | 2,974 |
| 2022 | 2,924 |
| 2023 | 9,952 |
| 2024 | 3,702 |
| 2025 | 2,810 |
| 2026 | 1,905 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,016,034 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| dependenceSignal | 7,835 | 91.8 | 89.8 | 604,808 |
| overdoseSignal | 3,935 | 10.2 | 9.9 | 32,505 |
| drug dependenceSignal | 2,205 | 7.7 | 7.4 | 12,677 |
| drug hypersensitivitySignal | 2,376 | 6.8 | 6.6 | 11,817 |
| vomitingSignal | 3,558 | 4.2 | 4.1 | 8,800 |
| pneumoniaSignal | 2,175 | 3.7 | 3.6 | 4,370 |
| painSignal | 3,205 | 2.9 | 2.8 | 4,052 |
| malaiseSignal | 2,106 | 2.7 | 2.5 | 2,210 |
| dyspnoeaSignal | 2,557 | 2.5 | 2.4 | 2,350 |
| dizzinessSignal | 2,143 | 2.4 | 2.3 | 1,741 |
| headacheSignal | 2,496 | 2.2 | 2.1 | 1,678 |
| nauseaSignal | 3,006 | 2.1 | 2.0 | 1,791 |
| fatigue | 2,488 | 1.8 | 1.7 | 854 |
| off label use | 2,551 | 1.6 | 1.5 | 611 |
| drug ineffective | 2,824 | 1.2 | 1.1 | 84 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.